Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Simpson

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Neurology|November 11, 2009
Determinants of survival in progressive multifocal leukoencephalopathyA Marzocchetti, T Tompkins, D B Clifford, et al.
Neurology|February 4, 2010
Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trialD M Simpson, G Schifitto, D B Clifford, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD M Simpson, A Blitzer, A Brashear, et al.
Neurology|January 6, 2012
Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against EpilepsyG L Birbeck, J A French, E Perucca, et al.
The Ulster Medical Journal|April 1, 1991
Human immunodeficiency virus infection in Northern Ireland 1980-1989R D Maw, J H Connolly, E E Mayne, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM Naumann, Y So, C E Argoff, et al.
Neurology|September 2, 2009
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review)Bruce H Dobkin, William M Landau, Shirley Sahrmann, et al.
European Journal of Pain (London, England)|January 23, 2013
Neuropathic pain needs systematic classificationN B Finnerup, J Scholz, N Attal, et al.
International Journal of STD & AIDS|August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilisC M Marra, R Deutsch, A C Collier, et al.
Neurology|January 10, 2002
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathyM Polydefkis, C T Yiannoutsos, B A Cohen, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Neurology|November 11, 2009
Determinants of survival in progressive multifocal leukoencephalopathyA Marzocchetti, T Tompkins, D B Clifford, et al.
Neurology|February 4, 2010
Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trialD M Simpson, G Schifitto, D B Clifford, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD M Simpson, A Blitzer, A Brashear, et al.
Neurology|January 6, 2012
Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against EpilepsyG L Birbeck, J A French, E Perucca, et al.
The Ulster Medical Journal|April 1, 1991
Human immunodeficiency virus infection in Northern Ireland 1980-1989R D Maw, J H Connolly, E E Mayne, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM Naumann, Y So, C E Argoff, et al.
Neurology|September 2, 2009
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review)Bruce H Dobkin, William M Landau, Shirley Sahrmann, et al.
European Journal of Pain (London, England)|January 23, 2013
Neuropathic pain needs systematic classificationN B Finnerup, J Scholz, N Attal, et al.
International Journal of STD & AIDS|August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilisC M Marra, R Deutsch, A C Collier, et al.
Neurology|January 10, 2002
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathyM Polydefkis, C T Yiannoutsos, B A Cohen, et al.
Pageof 19